As the 2026–2027 respiratory virus season begins, the American Academy of Family Physicians (AAFP), the American Academy of Pediatrics (AAP), and the American College of Obstetricians and Gynecologists (ACOG), and the Infectious Diseases Society of America (IDSA) have released 2026–2027 recommendations for COVID-19, influenza, and RSV vaccinations. These recommendations provide important guidance to support evidence-based vaccine discussions and help ensure patients receive timely protection against respiratory viruses.

August 28, 2026 (Montréal, QC):  Pharmacy leaders, invited from around the world, gathered in Montréal today for an international forum on advancing pharmacists’ integration into primary health care, where they identified workforce readiness, sustainable funding models, supportive regulatory frameworks and interprofessional collaboration as key conditions for consistent and sustainable integration. The findings will inform a joint CPhA–APhA report intended to support policy development and health-system implementation in Canada, the United States and internationally with FIP.

ASHP and APhA are deeply saddened by the reported harm experienced by Glenda Dorton and by the devastating impact this event has had on her family and loved ones. We also recognize that other patients were reportedly harmed, and our thoughts are with all those affected by this tragic event.

Childhood vaccine recommendations must be grounded in science. No new evidence has been found to justify significant changes to childhood immunization guidance, and decades of research involving millions of people show no link between vaccines and autism.

Washington, DC (July 17, 2026) — As the market for unregulated peptide products continues to grow, the American Pharmacists Association (APhA) is urging FDA and the Pharmacy Compounding Advisory Committee (PCAC) to prioritize patient safety, scientific evidence